DEVARTLab holds the 47th Scientific Conference Towards
Better Health to raise awareness about risks and prevention of heart disease
DEVARTLab, the pioneer in functional food and innovative pharmaceuticals,
organized its 47th conference "For A Better Quality of Life #
47", under title "Towards Better Health and Maximum Protection from
Cardiovascular Diseases", in the presence of best group of professors and
medical associations’ heads in Egypt, at Hurghada
The activities of
the scientific meeting began with DEVARTLab vision review, and the vision
impressed all audience including our eminent chairpersons, and meeting
continued with cardiology history in Egypt review
At the beginning of scientific meeting sessions, Prof. Dr. Islam Shawky, Professor of
Cardiology at Al-Azhar University and President of the Egyptian Heart
Association, spoke about the increase in the rates of arterial calcification in
the last decade and the extent of danger of calcium deposition on blood vessels’
wall and heart tissue in the deterioration of the health of patients with heart
disease, atherosclerosis, diabetes and kidney disease
He also addressed
the role of "Vitamin K2" in patient protection, preventing the
deposition of calcium on blood vessels’ wall and heart tissues, reducing
mortality rates resulting from arterial calcification, and its role in reducing
the complications of atherosclerosis.
Prof. Dr. Atef Al-Bahri also emphasized the increase in
atherosclerosis patients’ rate recently, and how lifestyle is a major factor in
increasing these rates, and the importance of finding a solution for this
problem
He also indicated
how to treat it from the beginning of diagnosis and the introduction of Advochol
10 mg of (rosuvastatin) by DEVARTLab, and its effectiveness in controlling the
levels of low-density lipids and triglycerides in blood.
Also, he spoke
about the importance of Mena Q to ensure that calcium is not deposited on blood
vessels’ wall and reduce atherosclerosis complications and the deterioration of
the disease
Dr. Hemmat Al-Haddad, Professor of
Internal Medicine, Diabetes and Endocrinology at Kasr Al-Ainy and Head of the
Intensive Care Unit at Kasr Al-Ainy pointed out that DEVARTLab offers new and
innovative solutions in the Egyptian pharmaceutical market, including Mena Q, Pharafero
18 and 18 Plus which is one of the best products in iron deficiency anemia management
due to its effectiveness without side effects such as abdominal pain,
constipation and other problems that have exhausted the Egyptian patient who is
looking for an optimum solution for iron deficiency anemia
More than 200 doctors, professors and consultants of cardiology,
internal Medicine, diabetes and nephrology from 20 governorates all over Egypt have attended the conference
